Abstract
Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have